Search IPOs
MDRCL
Modern Diagnostic & Research Centre IPO, a SME IPO was listed on the exchange on January 7, 2026. The price band is set between ₹85 –90 , with a face value of ₹10 . Retail investors can apply with a minimum of 2 lots, each comprising 1,600 shares — amounting to ₹288,000 at the upper price.
Modern Diagnostic & Research Centre IPO has been successfully listed on the exchange. Track the listing performance, current stock price, and post-listing trends. This information is for education only—not investment advice.
Modern Diagnostic & Research Centre IPO SME Important Dates
Get important updates regarding Modern Diagnostic & Research Centre IPO SME tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates. Dates are updated as soon as they are announced.
Issue price ₹90
Issue
₹90
Open Date
Dec 31
Close Date
Jan 02
Allotment
Jan 05
Listing
Jan 07
Issue Size
4,099,200 shares
(aggregating up to ₹36.89 Cr)
Issue Price
₹85 – ₹90
Face Value
₹10/share
Market Lot
1,600 shares
Retail Min Investment
₹288,000
Listing At
BSE
Sale Type
fresh issue
Offer for Sale
3,892,800 shares
(aggregating up to ₹35 Cr)
Reserved for Market Maker
206,400 shares
(aggregating up to ₹1.86 Cr)
Issue Type
book building
Last updated: 2 months ago
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 06 Jan 2026 Latest | ₹90 | ₹13.5 | ₹103.5 | ₹13.5 |
15%
|
3:17 PM |
| 05 Jan 2026 | ₹90 | ₹13.5 | ₹103.5 | ₹13.5 |
15%
|
3:17 PM |
| 04 Jan 2026 | ₹90 | ₹16 | ₹106 | ₹16 |
17.78%
|
3:17 PM |
| 03 Jan 2026 | ₹90 | ₹16 | ₹106 | ₹16 |
17.78%
|
12:00 PM |
| 02 Jan 2026 | ₹90 | ₹16 | ₹106 | ₹16 |
17.78%
|
12:00 PM |
| 01 Jan 2026 | ₹90 | ₹14 | ₹104 | ₹14 |
15.56%
|
12:00 PM |
| 31 Dec 2025 | ₹90 | ₹13 | ₹103 | ₹13 |
14.44%
|
12:00 PM |
| 30 Dec 2025 | ₹90 | ₹10 | ₹100 | ₹10 |
11.11%
|
12:00 PM |
Latest snapshot: Jan 02, 2026
| Category | Subscribed (x) | No. of Applications |
|---|---|---|
| QIB | 193.51x | — |
| NII | 702.08x | — |
| bNII (bids above ₹10L) | 855.83x | — |
| sNII (bids below ₹10L) | 386.91x | — |
| Retail Investors | 342.46x | — |
| Total | 376.9x | — |
Mr. Devendra Singh Yadav, Mrs. Deepali Yadav, Mrs. Asha Yadav, and Mr. Jitendra Singh are the promoters of the company.
IPO investment limits, also referred to as application limits or bidding limits, define the minimum and maximum number of shares, lots, and investment amount that investors can apply for in an IPO based on their category (Retail, HNI, or Institutional). These limits are calculated as per SEBI guidelines and help ensure fair distribution of shares. Retail investors typically have lower minimum and maximum limits compared to High Net Worth Individuals (HNI) and Non-Institutional Investors (NII). Understanding IPO application limits is essential for investors to determine how much they can invest, calculate the number of lots they can apply for, and plan their investment strategy accordingly. The investment limits table shows the lot size, number of shares, and total amount in rupees for each investor category.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 3,200 | ₹288,000 |
| Retail (Max) | 1 | 1,600 | ₹144,000 |
| S-HNI (Min) | 3 | 4,800 | ₹432,000 |
| S-HNI (Max) | 6 | 9,600 | ₹864,000 |
| B-HNI (Min) | 7 | 11,200 | ₹1,008,000 |
The IPO reservation structure, also known as share allocation breakdown, details how the total issue size is distributed among different investor categories as mandated by SEBI (Securities and Exchange Board of India) regulations. This reservation table shows the exact percentage and number of shares allocated to Qualified Institutional Buyers (QIB), Retail Individual Investors (RII), High Net Worth Individuals (HNI), Non-Institutional Investors (NII), and other reserved categories like employees and shareholders. Understanding IPO reservation percentages is crucial for investors to evaluate their probability of share allotment, as each category has different subscription levels and competition. The maximum allottees column indicates the cap on the number of investors who can receive shares in each category, helping you assess the likelihood of getting an allotment based on your investor category.
| Category | Shares Offered |
|---|---|
| QIB Shares Offered | 1,944,000 (47.43%) |
|
•
Anchor Investor Shares Offered
|
1,161,600 (28.34%) |
|
•
QIB (Ex. Anchor) Shares Offered
|
782,400 (19.09%) |
| NII (HNI) Shares Offered | 585,600 (14.28%) |
|
•
bNII > ₹10L
|
390,400 (9.52%) |
|
•
sNII < ₹10L
|
195,200 (4.76%) |
| Retail Shares Offered | 1,363,200 (33.26%) |
| Market Maker Shares Offered | 206,400 (5.03%) |
| Total Shares Offered | 4,099,200 (100.00%) |
Modern Diagnostic & Research Centre Limited is a diagnostic services provider in India that operates a network of 21 centers across 8 states, including 17 laboratories and 4 diagnostic centers.
They offer comprehensive radiology and pathology services such as ultrasound, CT scan, MRI, ECG, digital X-Ray, and advanced tests including molecular diagnostics and specialized panels. The company also provides home specimen collection, online reports, and customized institutional and patient diagnostic solutions.
Key Strengths:
Standalone · ₹ in Crores
| Particulars | FY 2023 | FY 2024 | FY 2025 Latest |
|---|---|---|---|
| Total Revenue | 56.61 | 68.67 |
78.8
↑ 14.8%
|
| Profit After Tax (PAT) | -5.73 | 5.79 |
8.97
↑ 54.9%
|
| EBITDA | -0.99 | 11.05 |
17.96
↑ 62.5%
|
| Total Assets | 36.54 | 49.49 |
64.57
↑ 30.5%
|
| Net Worth | 5.96 | 11.76 |
20.73
↑ 76.3%
|
| Reserves & Surplus | 4.96 | 10.76 |
9.73
↓ 9.6%
|
| Total Borrowing | 15.31 | 20.46 |
22.09
↑ 8.0%
|
Revenue & Profit Trend
The Modern Diagnostic & Research Centre IPO is expected to open in December, 2025, subject to SEBI approval. Final dates will be updated once announced officially.
The price band for Modern Diagnostic & Research Centre IPO is ₹85.00 - ₹90.00 per share.
As per market sources, Modern Diagnostic & Research Centre IPO GMP is currently ₹13.50. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Modern Diagnostic & Research Centre IPO stands at 376.90x overall.
The listing date for Modern Diagnostic & Research Centre IPO is January 7, 2026.
No comments yet. Be the first to comment!
